BioBoard
Australia • Australia Launches New Online Service to Explain Laboratory Tests • Australia Government Pledges US$86 Million to Indonesia to Fight HIV/AIDS
China • New Test Improves Detection of Liver Cancer • CAS Scientists Discover New Mechanism for Neural Stem Cell Maintenance • Price of Herbs to Increase in China
Hong Kong • Scientists from Chinese University of Hong Kong Discover New Treatment for Chronic Hepatitis C with Less Side Effects
India • AKCDA to Set Up Drug Information Center at Trichur in Kerala • India Invests in Nanotech Park in Bangalore • AKCDA to Set Up Drug Information Center at Trichur in Kerala • Serum Institute of India Launches Low-cost HIB Vaccine in India
Indonesia • WHO Urges Indonesia to Share Live H5N1 Virus Samples
New Zealand • New Zealand Minister Rejects GM Corn
Singapore • Singaporean Scientists Make Medical Breakthrough Findings in Crab Blood • IBN and Caltech to Tie Up in Nanomedicine South Korea • South Korean Scientist Created World's First "Virgin Birth" by Accident Taiwan • Leukemia Drug Used as a Treatment for Alzheimer's Disease Vietnam • Vietnam Finds Bird Flu Poultry Near China Border Special Feature • Risk Management of Complementary Alternative Medicines in Cancer • Complementary Therapies for Cancer Patients • Chinese Medicine and Cancer Treatment in Hong Kong: A General Review • Ten (Good) Reasons to Drink Green Tea Industry Watch • Apollo Succeeds in Needle-Free Drug Delivery Trials • HealthLink Enters New Trials for Ovarian Cancer Diagnostics • Sinovac and GlaxoSmithKline (China) Investment Co Enters Exclusive Promotion Service Agreement • Hong Kong University of Science and Technology to Award Exclusive License to MitoPharm • GVK Biosciences to Provide Clinical Biomarker Database to USFDA Genomics Group • Ranbaxy Commercializes its First Authorized Generic Product in the US • KineMed Inc Extends Alliance with CMIC • Kyowa Hakko Licenses BioWa Novel Antibody Engineering Technology • Japan's Bioventure Today — UMN Pharma Inc • Abott Picks Singapore for Trial of New Drug • A*STAR and NUS Establish New Clinical Imaging Research Center with Siemens Product News • Powerful Finger-Printing Technology Identifies Novel Targets for Gleevec Commentaries and Analyses • Accelerating the Renaissance in Bioscience Entrepreneurship in Asia Part I Interview • Interview with Beijing Tong Ren Tang/Science Arts Conference Calendar
South Korea • South Korean Scientist Created World's First "Virgin Birth" by Accident
Taiwan • Leukemia Drug Used as a Treatment for Alzheimer's Disease
Vietnam • Vietnam Finds Bird Flu Poultry Near China Border
Special Feature • Risk Management of Complementary Alternative Medicines in Cancer • Complementary Therapies for Cancer Patients • Chinese Medicine and Cancer Treatment in Hong Kong: A General Review • Ten (Good) Reasons to Drink Green Tea
Industry Watch • Apollo Succeeds in Needle-Free Drug Delivery Trials • HealthLink Enters New Trials for Ovarian Cancer Diagnostics • Sinovac and GlaxoSmithKline (China) Investment Co Enters Exclusive Promotion Service Agreement • Hong Kong University of Science and Technology to Award Exclusive License to MitoPharm • GVK Biosciences to Provide Clinical Biomarker Database to USFDA Genomics Group • Ranbaxy Commercializes its First Authorized Generic Product in the US • KineMed Inc Extends Alliance with CMIC • Kyowa Hakko Licenses BioWa Novel Antibody Engineering Technology • Japan's Bioventure Today — UMN Pharma Inc • Abott Picks Singapore for Trial of New Drug • A*STAR and NUS Establish New Clinical Imaging Research Center with Siemens
Product News • Powerful Finger-Printing Technology Identifies Novel Targets for Gleevec
Commentaries and Analyses • Accelerating the Renaissance in Bioscience Entrepreneurship in Asia Part I
Interview • Interview with Beijing Tong Ren Tang/Science Arts
Conference Calendar
